Non-Performing Assets / Total Loans: A classification used by financial institutions that refer to loans that are in jeopardy of default as a potion of total loans made. Calculated as: Non-Perfroming Assets / Gross Loans Made
Corvus Pharmaceuticals, Inc. (CRVS) Non-Performing Assets / Total Loans data is not available.
| Income Statement Financials | |
-- |
|
$-62.29M |
|
-- |
|
-- |
|
$27.55M |
|
$-27.55M |
|
$-34.74M |
|
$-62.29M |
|
$-62.30M |
|
$-62.29M |
|
$-62.29M |
|
$-62.29M |
|
$-62.30M |
|
$-27.55M |
|
$-28.60M |
|
60.99M |
|
60.99M |
|
$-1.02 |
|
$-1.02 |
|
| Balance Sheet Financials | |
$54.41M |
|
$0.15M |
|
$14.50M |
|
$68.91M |
|
$35.40M |
|
-- |
|
$0.94M |
|
$36.34M |
|
$32.57M |
|
$32.57M |
|
$32.57M |
|
67.90M |
|
| Cash Flow Statement Financials | |
$-25.42M |
|
$-27.48M |
|
$49.03M |
|
$12.62M |
|
$8.74M |
|
$-3.88M |
|
$3.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.54 |
|
|
Non-Performing Assets / Total Loans |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-25.42M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-191.27% |
|
-191.27% |
|
-90.40% |
|
-191.27% |
|
$0.48 |
|
$-0.42 |
|
$-0.42 |
|